The Claim
Anti-VEGF therapy is indicated for the treatment of diabetic macular edema with vision loss, and laser photocoagulation is used to prevent severe vision loss in proliferative diabetic retinopathy.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Anti-VEGF injections are used to treat vision loss caused by diabetic macular edema, and laser treatment is used to prevent severe vision loss in advanced diabetic eye disease.
See the scientific wording
Anti-VEGF therapy is indicated for diabetic macular edema with vision loss, and laser photocoagulation is used to prevent severe vision loss in proliferative diabetic retinopathy.
High blood sugar damages retinal cells, causing them to release a protein that makes blood vessels leak fluid and grow abnormally. This fluid buildup swells the central part of the eye, blurring vision, while the abnormal vessels can bleed and scar, threatening sight. Blocking this protein reduces swelling, and laser treatment destroys areas of damaged tissue to stop the signals that trigger abnormal vessel growth.
What the research says
1 studyStudy: Diabetic retinopathy
For diabetic eye swelling that hurts vision, doctors use special eye shots to block a harmful protein; for advanced eye disease with leaky blood vessels, they use laser treatment to stop blindness. The study says exactly that.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.